MedTrace Logo

Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

NCT02068989 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2016-09-05

No results posted yet for this study

Summary

We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.

Conditions

  • Stress Hyperglycemia
  • Diabetes Mellitus Type 2

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Stephen Atlas, MD · Yale New Haven Hospital

  • Jonathon Fine, MD · Norwalk Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02068989 on ClinicalTrials.gov